Geneos Wealth Management’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-57
Closed -$798 2493
2025
Q2
$798 Sell
57
-13
-19% -$209 ﹤0.01% 3041
2025
Q1
$1.3K Buy
+70
New +$1.04K ﹤0.01% 3026

Other funds holding ALHC

Geneos Wealth Management's ALHC Position: Q3 2025 in Review

Geneos Wealth Management sold out of Alignment Healthcare (ALHC) in Q3 2025, closing a stake of 57 shares — an estimated $798 sold.

Geneos Wealth Management first reported a position in ALHC in Q1 2025 and held it in 2 quarters. The position peaked at $1.3K in Q1 2025. 236 funds tracked by Wall St. Rank hold ALHC as of Q3 2025.

  • Geneos Wealth Management reported no remaining Alignment Healthcare position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 57 Alignment Healthcare shares in Q3 2025, an estimated $798.
  • Geneos Wealth Management first reported a position in Alignment Healthcare in Q1 2025 and held it in 2 quarters.
  • Geneos Wealth Management's Alignment Healthcare position peaked at $1.3K in Q1 2025.
  • 236 funds tracked by Wall St. Rank held Alignment Healthcare as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.